By simulating molecular disruptions in ischemic optic neuropathy, optic neuritis, and other vision-related conditions, AI models guide treatment decisions, from TF pathway restoration in hypoxic environments to inflammation-targeted therapeutics in optic neuritis. The gene discussed is TF; the disease is optic neuritis.